Skip to main content
International Journal of Physiology, Pathophysiology and Pharmacology logoLink to International Journal of Physiology, Pathophysiology and Pharmacology
. 2016 Sep 30;8(3):109–110.

A novel AMPK activator from Chinese herb medicine and ischemia phosphorylate the cardiac transcription factor FOXO3

Jingying Wang 1,*, Heng Ma 1,*, Xiaoyu Zhang 2, Leilei He 1, Jianming Wu 3, Xiaoping Gao 3, Jun Ren 1, Ji Li 1
PMCID: PMC5078482  PMID: 27785337

Abstract

Oleanolic Acid (OA) is a nature product extracted from Chinese Herb Medicine which is traditionally used as treatment of diabetes and ischemic heart diseases. Mounting evidence showed that AMP-activated protein kinase (AMPK) has cardioprotective effect against ischemic injury and the forkhead transcription factor 3 (FOXO3) was recently identified as a downstream target of AMPK. We hypothesize that OA may protect against ischemic dysfunction of cardiomyocytes via activation of AMPK signaling pathway. Male C57BL/6 mice which were subjected to in vivo regional cardiac ischemia stimulated AMPK Thr172 phosphorylation, as well as phosphorylation of downstream FOXO3 (Ser413) and acetyl CoA carboxylase (ACC). The natural product, OA, significantly stimulated cardiac AMPK activation in cardiomyocyes in time- and dose-dependent manners. The mechanism of AMPK activation by OA may be due to the loss mitochondrial membrane potential (ΔΨm) as shown by JC-1 fluorescence assay. Intriguingly, OA as an AMPK activator also triggered FOXO3 (Ser413) phosphorylation in cardiomyocytes. Furthermore, OA treatment can protect cardiomyocytes from contractile dysfunction induced by hypoxia. Taken together, the results indicated that both ischemia and OA stimulated cardiac AMPK phosphorylation, as well downstream FOXO3 phosphorylation. The cardioprotective effect of OA maybe associated with activation of AMPK signaling pathways.

Keywords: AMP-activated protein kinase (AMPK), ischemia, forkhead transcription factor 3 (FOXO3), oleanolic acid (OA)


In this paper, Figure 3A contained an error, which is corrected in Figure below. The panel A of Figure 3 shows the Western blotting result of OA stimulating AMPK activation in cardiomyocytes. A wrong panel of AMPKα was used for Figure 3A (upper left panel) during the manuscript preparation. The wrong panel has been replaced in the new figure as shown below. We apologize for any inconvenience occurred. This change does not affect the conclusions of the paper.

Figure 3.

Figure 3

OA activated AMPK signaling pathway in isolated mouse cardiomyocytes. OA stimulated AMPK phosphorylation in (A) dose-dependent and (B) time-dependent manner. Phosphorylation of (C) ACC (Ser79) and (D) p38 MAPK (Thr180/Tyr182) were activated by OA in time dependent manner. Values are means ± SE (n=3). #p<0.01 vs. control (DMSO); *p<0.05 vs. control (DMSO).


Articles from International Journal of Physiology, Pathophysiology and Pharmacology are provided here courtesy of e-Century Publishing Corporation

RESOURCES